Head and Neck Squamous Cell Carcinoma (HNSCC) Recruiting Phase 2 Trials for DB00958 (Carboplatin)

Also known as: Head and Neck Squamous Cell Carcinoma

IndicationStatusPhase
DBCOND0043665 (Head and Neck Squamous Cell Carcinoma (HNSCC))Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02270814Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable Head and Neck Squamous Cell CarcinomaTreatment